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SUMMARY
Serological assays using dried blood spots from 5221 women in rural areas of eastern Zimbabwe
were used to assess the epidemiology of Trichomonas vaginalis infection, and its association with
HIV. Antibodies to T. vaginalis and to HIV were detected by enzyme immunoassays. Behavioural
and demographic data were collected by conﬁdential questionnaires. In total, 516 (9.9%) women
were seropositive for T. vaginalis and seroprevalence increased with age among younger women.
Divorced, widowed and single women were more likely to be seropositive. After controlling for
age, seropositivity was signiﬁcantly associated with being sexually active, having multiple sex
partners, having a partner who had multiple sex partners, and having a new sex partner in the
past year. Seropositivity was associated with a recent history of genital discharge. Overall, 208
(40.3%) T. vaginalis-positive samples were also positive for HIV, compared with 1106 (23.5%)
T. vaginalis-negative samples (age and sex adjusted OR 2.11, 95% CI 1.74–2.55, P<0.001). There
was increased risk for being HIV-positive amongst T. vaginalis-seropositive women regardless of
residence, employment or education. In a logistic regression controlling for common risk factors,
the association remained signiﬁcant. T. vaginalis-seropositive young women with a history of
genital discharge were much more likely to be HIV-positive than women who were T. vaginalis-
seronegative and had no history of discharge (OR 6.08, 95% CI 2.95–12.53). Although a causal
relationship cannot be assumed, detection and treatment of trichomoniasis may be important in
strategies to reduce HIV transmission through sexually transmitted infection control.
INTRODUCTION
Trichomonas vaginalis infection is among the most
frequently occurring sexually transmitted infections
(STIs), and is associated with vaginitis, urethritis and
cervicitis and with adverse outcomes in pregnancy [1].
In Zimbabwe, the prevalence of trichomoniasis may
be as high as 50% in women attending genitourinary
clinics [2], while asymptomatic carriage of T. vaginalis
has been shown in approximately 10% women at-
tending family-planning clinics [3]. Normal methods
of detection – microscopy and/or culture of vaginal or
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urethral swabs – are not appropriate for community
investigations. Techniques such as polymerase chain
reaction assays have been used with self-collected
specimens [4], but these are expensive and are not
widely available in developing country settings.
Information on the epidemiology of trichomoniasis
infection in the general population is, therefore, lim-
ited. In a rural area of Uganda, a population-based
study in which women used self-administered vaginal
swabs, found a prevalence of infection of 47% [5].
Epidemiological and biological studies have dem-
onstrated a signiﬁcant role for STIs as co-factors
facilitating HIV transmission. The success of a
community-based STI detection and treatment pro-
gramme in reducing HIV transmission lends support
to this hypothesis [6]. Inﬂammation of the urogenital
tract both increases viral shedding and increases
susceptibility to HIV infection [7] and untreated
STIs have, therefore, been suggested as contributing
signiﬁcantly to the high prevalence of HIV in sub-
Saharan Africa [8]. Chronic asymptomatic infections
that go undetected and untreated may also be
important factors in HIV transmission, and infection
with T. vaginalis may be important in this regard [9].
Studies in Malawi have shown that urethritis in men is
associated with increased levels of HIV in semen, and
treating urethritis reduces these levels [10]. Elsewhere
in Africa a programme of community mass treatment
for common STIs, including trichomoniasis, showed
no major impact on HIV seroincidence [11]. There
are, however, a number of explanations for this,
including the lack of treatment for Herpes simplex
infection, and the continued prevalence of trichomo-
niasis and symptoms of urethritis, despite the inter-
vention.
In most cases, an STI is detected by microscopy and
culture, methods that are applicable only to current,
even if asymptomatic, infection. Detection of HIV
infection, however, is usually carried out using serol-
ogy and antibodies to HIV may only be found weeks
or months after the event leading to infection
occurred. As a consequence, attempts to identify an
epidemiological association between current infection
events, such as symptomatic STI episodes, and past
infection events, such as HIV, may be diﬃcult to
establish. Serological assays, however, are indicative
of the entire past history of exposure to speciﬁc anti-
gens, and so may be more useful in detecting these
associations.
Recently we evaluated an enzyme immunoassay
(EIA) that detects exposure to trichomonal infection,
and found it had a sensitivity >90% in men and
women at high and low risk of having had a T. vagi-
nalis infection [12]. Here, we present data from a
subsequent evaluation of this EIA in detecting anti-
trichomonal antibody in dried blood spot (DBS)
specimens collected in community studies. We
describe the seroepidemiology of T. vaginalis infection
in women and the association between seropositivity
for T. vaginalis and HIV in rural communities in
eastern Zimbabwe.
MATERIALS AND METHODS
The samples for the current study were collected in the
course of broader programmes of research on the
epidemiology, control and impact of HIV in men and
women in the Mutasa, Makoni and Nyanga districts
of Manicaland, Zimbabwe’s eastern province. The
study design and ﬁnger-prick DBS sample collection
procedures were approved by both the Institutional
Review Board of the Biomedical Research & Training
Institute, and by the Medical Research Council of
Zimbabwe and are reported elsewhere [13]. All
research participants gave informed written consent
to serological screening for STI and HIV. Samples
were labelled with reference numbers and tests were
conducted anonymously. Parallel services for STI
treatment and voluntary counselling and testing for
HIV infectionweremade available. Sociodemographic
and epidemiological data were collected by standard
questionnaire in a conﬁdential setting. Data on sexual
behaviour were collected using an informal, conﬁ-
dential, voting interview procedure [14].
Specimen collection and processing procedures
In addition to DBS, whole blood specimens were
collected from a subsample of 102 men and women
participating in the main study. These paired samples
were used to evaluate DBS samples for serological
testing for HIV and T. vaginalis. Serum was separated
from the whole blood samples after centrifugation
and was stored at x20 xC in 250-ml aliquots. The
blood spots were collected on Whatman No. 1 ﬁlter
papers. The ﬁlter papers were air dried and stored
at room temperature in individual paper packets. In
the laboratory, a 10-mm diameter circle was cut
from each blood spot and placed into a tube with
400 ml PBS. After incubation overnight at 4 xC, the
eluate was removed and used for serological tests.
The DBS eluates were regarded as a 1:20 dilution of
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serum [15] for the purposes of subsequent serological
testing. Sera were tested immediately after thawing
and DBS eluates were used within 24 h of prep-
aration.
In the main study, DBS samples only were obtained
from 4166 men (aged 17–49 years) and 5299 women
(aged 15–49 years). These donors were residents of
small towns, roadside trading centres, large-scale
commercial farming estates (mainly tea, coﬀee and
forestry plantations), and (‘communal ’) subsistence
farming areas. Individuals who wished to receive HIV
test results provided a separate whole blood sample
that was tested independently of the DBS eluate. This
separate examination was also used for purposes of
quality control.
Laboratory investigations
For detection of anti-trichomonal antibodies, we fol-
lowed the EIA protocol described previously using an
antigen derived from a Mycoplasma-free isolate of
T. vaginalis [12]. Approximately 30 000–50 000 cells
were inoculated into the wells of microtitre plates,
which were then air dried and ﬁxed with methanol.
The test has been shown to have high sensitivity
(95%) and speciﬁcity (85%) in women with a current
T. vaginalis infection, and also to detect probable past
exposure to trichomonal antigens. Specimens that
gave borderline results (OD=0.4–0.5) were re-tested
and, if still borderline, were regarded as indeterminate
for the purpose of this analysis and excluded.
Antibodies to HIV-1 and HIV-2 were detected in
both serum and DBS eluates using an EIA (ICL
HIV-1/2 dipstick, Bangkok, Thailand) that has been
evaluated under local conditions [16]. Sera that gave
borderline results were subjected to a second assay
for conﬁrmation (Abbott 3rd Generation HIV-1/2
EIA, USA or Genelavia MIXT HIV-1/2, Sanoﬁ
Diagnostics, Pasteur SA, France).
Data analysis
Sociodemographic, epidemiological and sexual
behaviour data collected in the population survey
together with results from the serological tests were
entered and validated using SPSS-PC (SPSS Inc.,
Chicago, IL, USA). Statistical analyses, including
estimation of adjusted odds ratios for HIV infection
given positive serological test results for exposure to
T. vaginalis infection using logistic regression, were
conducted in STATA version 5 (StataCorp, TX, USA).
RESULTS
Evaluation of EIAs for T. vaginalis and HIV
infections when applied using DBS
Concordant T. vaginalis EIA test results were ob-
tained in 100/102 (98%) of the paired serum and DBS
samples. The test gave 14 (13.7%) positive results in
the serum samples, 12 (85.7%) of which were also
positive when the DBS eluates were tested. In both
discrepant cases, the serum OD value was 0.5, the
lower limit of positivity in our laboratory. Twenty-
nine (28.4%) serum specimens were positive for HIV
antibodies using the ICL dipstick EIA. In 28 (96.6%)
of these cases, the same assay also gave positive re-
sults with the DBS samples. The Abbott EIA gave
positive results with 31 sera (30.3%), and 29 (93.5%)
of the matched DBS samples also gave positive HIV
test results. In one case, the serum was repeatedly
positive but the DBS eluate was negative by both ICL
dipstick and Abbott EIA. This serum was also posi-
tive by Genelavia and the DBS eluate result was re-
garded as a false-negative. In each case where the
serum was negative, the DBS eluate was also negative.
Population seroepidemiology of T. vaginalis antibodies
The prevalence of T. vaginalis and HIV in the com-
munity was determined from DBS eluates only. The
T. vaginalis EIA gave indeterminate results in 16
(0.4%) men and 78 (1.5%) women, and these were
excluded from further analysis. Within the remainder,
the prevalence of antibodies to T. vaginalis was 1.1%
(47/4150) in men and 9.9% (516/5221) in women and
antibodies to HIV was 19.2% (797/4150) in men and
25.2% (1316/5221) in women. Because of the very low
number of T. vaginalis-seropositive men, they were
excluded from subsequent analysis.
Infection with T. vaginalis occurred early in women
with 10% of female respondents being seropositive
before the age of 20 years (Fig.). Seroprevalence in
women peaked in the late twenties but remained high
throughout the reproductive age-range.
The highest seroprevalence was found amongst
residents of roadside trading centres – with lower
prevalence levels being found in commercial farming
estates, small towns and subsistence farming areas
(Table 1). Seroprevalence was higher in respondents
with no formal education and in subsistence farmers,
and was also low in students. However, these patterns
probably reﬂect age diﬀerences in socioeconomic
status and the marked increases in education levels
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that have taken place in Zimbabwe since indepen-
dence in 1980.
Women who were currently divorced, widowed or
sexually active but not yet married were more likely to
be seropositive. A number of women who reported
having not yet started sex were found to be sero-
positive for T. vaginalis. This may indicate inaccuracy
in responses to questions concerning sexual behaviour,
especially as the HIV seroprevalence in this group was
also implausibly high. Qualitative studies in the proj-
ect areas and evaluations of the sexual behaviour data
using other biomarkers have shown that misreporting
of onset of sexual activity can occur [17].
After controlling for age, a positive T. vaginalis
serological test was associated with onset of sexual
activity, with having multiple lifetime sexual partners,
with having had a new sexual partner in the preceding
year, and with having a regular partner who has
multiple sexual partners (Table 1). The chances of
having a positive T. vaginalis test result rose with
increasing numbers of lifetime sexual partners (age-
adjusted OR 1.02, 95% CI 1.00–1.04, P=0.088).
There was evidence for an association between a
history of genital discharge and T. vaginalis infection,
but the association was only apparent in those women
reporting a discharge within the last year rather than
longer ago. There were 316/3478 (9.1%) women with
no history of a discharge who were seropositive,
compared to 132/1115 (11.8%) women reporting a
discharge in the previous year (OR 1.34, 95% CI
1.08–1.68, P=0.007) and 11/180 (6.1%) women
reporting discharge more than 12 months previously
(OR 0.65, 95% CI 0.35–1.25, P=0.173). For this
analysis, women reporting lower abdominal pain in
the past year, but who did not report a history of
genital discharge were included in the reference cat-
egory. If these are excluded completely, the eﬀects
noted here strengthen further: the age-adjusted odds
ratios for a positive T. vaginalis EIA result in women
with a recent history of discharge increase to 1.36
(95% CI 1.09–1.70, P=0.006).
Table 1. T. vaginalis (TV) seroprevalence by
sociodemographic status and sexual behaviour
Characteristic TV % n OR P
Location
Subsistence farm 7.1 1996 1
Small town 8.0 777 1.13 0.433
Commercial farm 9.3 1397 1.33 0.021
Trading centre 17.3 1051 2.73 <0.001
Education
None 16.8 208 1
Primary 11.1 2239 0.62 0.015
Secondary or higher 8.4 2773 0.45 <0.001
Employment
Subsistence farming 13.5 341 1.45 0.041
Married – cohabiting 9.7 1433 1
Married – living apart 8.5 1494 0.94 0.616
Divorced or widowed 14.7 1009 1.60 <0.001
Beer-hall attendance last month
Self – yes 11.9 202 1.25 0.312
Self – no 9.7 4991 1
Regular partner – yes 9.8 1845 1.10 0.447
Regular partner – no 9.3 992 1
Lifetime sexual partners
0 4.8 942 0.56 <0.001
1 9.3 2677 1
2 13.7 795 1.54 <0.001
o3 15.1 720 1.62 <0.001
New partner in last year
No (but sexually active) 10.0 2729 1
Yes 13.9 771 1.54 <0.001
Partners in the last month
0 (but previously active) 13.3 1551 1
1 9.9 2579 0.72 0.001
o2 8.8 80 0.63 0.251
Regular partner has non-marital partner in the last year?
0 8.6 973 1
1 10.8 481 1.27 0.197
o2 12.6 286 1.44 0.217
Time since last had sex
>1 year (but started) 13.6 722 1
1–12 months 12.8 963 0.95 0.716
<1 month 9.6 2592 0.69 0.003
Last partner was
Regular 9.6 2335 1
Casual 12.8 188 1.42 0.133
OR, Odds ratio for T. vaginalis seropositivity in relation to
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Fig. T. vaginalis seroprevalence with 95% conﬁdence inter-
vals for women aged 15–49 years.
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Association between T. vaginalis and HIV infections
There was a strong overall association between sero-
positivity for T. vaginalis and HIV, with 208/516
(40.3%) T. vaginalis-positive samples being HIV-
positive, compared to 1106/5221 (23.5%) of the T.
vaginalis-negative samples (age adjusted OR 2.11,
95% CI 1.74–2.55, P<0.001).
Increased risk for being HIV-positive in women
with positive serology for T. vaginalis was found
regardless of residence, employment or educational
level (Table 2). The association was strongest at
young age, almost certainly reﬂecting selection for
early sexual activity, and relatively weak (but still
present) at age o30 years. The latter probably con-
tributes towards the absence of an association
amongst widows and women with no formal school
education, as most of these would be older women.
The results of logistic regression analyses of the
association between positive serologies for T. vagi-
nalis and HIV infections after controlling for common
risk factors is shown in Table 3. The results of a sep-
arate analysis for young women (<25 years) are pres-
ented as they shed some light on the possible strength
of this association at ages where prevalence is likely to
reﬂect incidence most closely for both infections.
These results show that area of residence, age,
marital status, employment sector, beer-hall attend-
ance and several speciﬁc aspects of sexual behaviour
including cumulative number of lifetime sexual part-
ners and regular partner’s number of non-marital
partners, are all important risk factors for HIV as well
Table 2. Prevalence of HIV infection in women by T. vaginalis (TV) serology
Sociodemographic group
TV positive TV negative






All sites 40.3 516 23.5 4705 2.19 (1.82–2.65) <0.001
Small town 64.5 62 41.7 715 2.54 (1.48–4.37) 0.001
Commercial farm 46.2 130 22.8 1267 2.90 (2.01–4.19) <0.001
Trading centre 31.3 182 20.4 869 1.78 (1.25–2.54) 0.001
Subsistence farm 35.9 142 18.5 1854 2.47 (1.72–3.55) <0.001
Age group (years)
15–19 31.3 80 5.3 1155 8.15 (4.76–13.97) <0.001
20–24 45.5 101 24.1 905 2.64 (1.73–4.01) <0.001
25–29 57.9 95 37.4 738 2.30 (1.49–3.55) <0.001
30–34 37.3 59 39.5 582 0.91 (0.52–1.58) 0.738
35–39 42.7 75 30.7 592 1.68 (1.03–2.74) 0.039
40–44 26.7 86 18.7 589 1.59 (0.94–2.68) 0.081
45–49 25.0 20 20.8 144 1.27 (0.43–3.76) 0.671
Marital status
Single – not started sex 15.6 45 1.7 897 10.83 (4.17–28.12) <0.001
Single – started sex 54.3 46 22.5 293 4.09 (2.16–7.78) <0.001
Married – live together 30.9 139 24.6 1293 1.37 (0.94–2.01) 0.102
Seasonally separated 30.7 137 20.8 1357 1.69 (1.15–2.48) 0.008
Permanently separated 64.9 94 45.7 516 2.19 (1.86–3.26) 0.001
Widowed 55.6 54 55.2 344 1.01 (0.57–1.80) 0.979
Education level
None 37.1 35 29.5 173 1.41 (0.66–2.02) 0.372
Primary 42.2 249 26.9 1990 1.98 (1.51–2.59) 0.001
Secondary or higher 38.8 232 20.5 2540 2.46 (1.86–3.26) <0.001
Employment status
Subsistence farmer 44.6 193 26.2 1468 2.27 (1.67–3.08) <0.001
Formal sector 55.4 65 28.4 656 3.13 (1.87–5.25) <0.001
Unemployed 35.8 229 25.2 2107 1.66 (1.24–2.21) 0.001
Student 11.5 26 1.1 466 12.03 (2.71–53.43) <0.001
OR, Odds ratio for HIV infection.
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Table 3. Odds ratios for HIV infection in women with positive T. vaginalis (TV) serology in the presence and
absence of symptoms, adjusted for sociodemographic and behavioural risk factors
Characteristic
All women (15–49 years)
(n=4183)
Young women only (15–24 years)
(n=1274)
OR (95% CI) P OR (95% CI) P
STD symptoms and TV
TV positive, genital discharge ever 2.89 (2.00–4.15) <0.001 6.08 (2.95–12.53) <0.001
TV positive – no genital discharge 1.77 (1.33–2.35) <0.001 3.18 (1.92–5.26) <0.001
TV negative – genital discharge ever 1.51 (1.28–1.78) <0.001 1.52 (1.09–2.10) 0.013
TV negative, no genital discharge 1 1
Location
Small town 2.73 (2.19–3.40) <0.001 2.37 (1.92–5.26) <0.001
Commercial farm 1.22 (1.00–1.50) 0.053 1.37 (0.93–2.01) 0.108
Trading centre 0.98 (0.79–1.21) 0.862 0.77 (0.50–1.21) 0.258
Subsistence farm 1 1
Age group (yr) Age (yr)
15–19 1 15 1
20–24 1.69 (1.23–2.33) 0.001 16 2.89 (0.31–27.14) 0.352
25–29 2.41 (1.74–3.33) <0.001 17 3.02 (0.36–25.65) 0.311
30–34 2.19 (1.56–3.08) <0.001 18 2.71 (0.32–23.08) 0.362
35–39 1.56 (1.10–2.21) 0.012 19 4.79 (0.5–38.85) 0.142
40–44 0.74 (0.52–1.07) 0.111 20 0.79 (0.34–22.78) 0.339
45–49 0.67 (0.40–1.12) 0.127 21 6.20 (0.77–50.20) 0.087
22 8.04 (1.00–64.64) 0.050
23 5.71 (0.71–45.74) 0.101
24 9.25 (1.15–74.40) 0.037
Marital status
Single 1 1
Married – cohabiting 0.90 (0.64–1.26) 0.534 1.01 (0.62–1.66) 0.953
Married – live apart seasonally 0.93 (0.66–1.31) 0.681 0.76 (0.46–1.27) 0.299
Divorced or separated 1.94 (1.40–2.70) <0.001 1.34 (0.82–2.21) 0.243
Widowed 5.01 (3.43–7.32) <0.001 3.29 (1.34–8.12) 0.010
Employment
Subsistence farmer 1 1
Formal sector 0.74 (0.59–0.95) 0.016 0.59 (0.36–0.96) 0.034
Unemployed 0.93 (0.79–1.10) 0.395 0.81 (0.59–1.11) 0.194
Student 0.28 (0.08–0.96) 0.043 0.51 (0.14–1.88) 0.312
Beer-hall attendance in last month
Not visited a beer-hall 1 1
Visited a beer-hall 1.38 (0.96–1.97) 0.083 1.41 (0.55–3.59) 0.477
Partner not visited a beer-hall 1 1




2 1.79 (1.48–2.16) <0.001 2.08 (1.44–2.99) <0.001
3 2.54 (1.94–3.32) <0.001 2.99 (1.81–4.95) <0.001
o4 3.62 (2.79–4.70) <0.001 3.20 (1.88–5.45) <0.001
Regular partner has other
partners in last year
0 1 1
1 1.11 (0.90–1.36) 0.327 0.92 (0.61–1.37) 0.674
2 1.14 (0.82–1.59) 0.441 1.27 (0.69–2.33) 0.447
o3 1.40 (1.00–1.96) 0.050 1.21 (0.68–2.15) 0.509
Age at ﬁrst sex, partners in last month, time since last sex and education all had small, not signiﬁcant eﬀects in each age range.
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as T. vaginalis in this rural population. However, after
controlling for these factors, the strong association
between positive T. vaginalis and HIV serologies
remains. Women with positive T. vaginalis serology
coupled with a self-reported history of genital dis-
charge are almost three times as likely to be HIV-
positive than those with negative serology and no
history of this symptom. However, even those with
positive T. vaginalis serology but who do not report a
history of genital discharge were found to be at
signiﬁcantly greater risk of having been infected with
HIV. Both of these eﬀects were particularly strong in
the 15–24 years age group, despite controlling for
reported number of lifetime partners, and remained
so even when the eﬀect of age at ﬁrst sex was tested in
the regression model.
DISCUSSION
The overall seroprevalence of HIV in this rural cohort
was slightly lower than reported in studies of pregnant
(33%) [18] or non-pregnant (30–35%) [19] women in
Harare. This is consistent with many studies showing
small diﬀerences in HIV prevalence between urban
and rural communities, and such diﬀerences have also
been noted when comparing small urban sites and
rural sites in this study area [12]. Well-recognized
risk factors for prevalent HIV include a recent self-
reported history of STI and having multiple sex
partners. Similar epidemiological patterns were
identiﬁed using DBS eluates in this rural cohort. This
ﬁnding and the direct comparison we were able to
make between results using serum and DBS eluates on
a limited number of participants give us conﬁdence
that the results using eluates are a true reﬂection of
HIV serology in this population. Equally, the high
level of concordance between the results obtained
using DBS eluates and serum samples drawn from the
same individuals and the plausibility and external
consistency [1, 20] of the epidemiological results
encourage us to believe that the T. vaginalis results
based on DBS eluates are also essentially valid.
Marked diﬀerences have been reported in the
clinical presentation and natural history of tricho-
monal infection in men and women [20]. In men, most
infections are mild [21] and if untreated the duration
of carriage is estimated to be 1–4 months [22]. This
may inhibit the production of anti-trichomonal anti-
body, resulting in the low seroprevalence recorded
here and in previous investigations of asymptomatic
men [12]. In women, the acute infection is usually
symptomatic, but chronic carriage may follow, with
an estimated duration of several years, if not for life
[22], and most women with a trichomonal infection
have antibodies [12]. Both past and current infections
are detected by serology, and positive serology may,
therefore, relate to both active acute trichomoniasis,
to chronic carriage or even to past episodes of tri-
chomoniasis. This may however be an advantage in
examinations of epidemiology, or of association with
other infections where the time of actual infection is
unknown, but where historical data on behaviour is
available.
The seroprevalence data presented here are con-
sistent with previous data on the prevalence of active
trichomoniasis in asymptomatic women in an urban
environment [3], and also are consistent with many
aspects of the epidemiology of trichomoniasis.
Seroprevalence increased markedly with age in young
women, and remained high in older women, a pattern
that has previously been described for trichomoniasis
using microscopy and culture and has been attributed
to the long duration of infection in women (reviewed
in ref. [22]). The association between seropositivity
and numbers of lifetime sexual partners also is con-
sistent – the presence of an STI with a long duration
of infection generally being most strongly correlated
with indicators that reﬂect risk behaviour over simi-
larly long time intervals and vice versa [22].
The strong association between T. vaginalis infec-
tion and HIV infection seen here in women is not
surprising given the long duration of both infections
and the common behavioural risk factors for trans-
mission and acquisition. In women, a positive T.
vaginalis serology may, in fact, be a useful marker for
cumulative risk behaviour for (prevalent) HIV infec-
tion, particularly at younger ages. Equally, if the EIA
used here detects mainly current or recent T. vaginalis
infection, it is possible that positive serology could be
a useful marker for behaviour associated with recent
acquisition (incidence) of HIV infection.More data on
the kinetics of serological responses to trichomonal
antigens would be useful in this context. Whether
detecting recent or past infection, T. vaginalis serology
might be used in the validation of self-reported sexual
behaviour data, and indeed, trichomoniasis has been
used as an indicator of poor compliance with use of
the female condom [23].
The persistence of the association between T. vagi-
nalis and HIV infection across diﬀerent socio-
economic and demographic subgroups and the very
strong association that remained after controlling for
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the common risk factors are suggestive of a causal
link. While a biological risk – through promotion of
urethral or vaginal discharge containing large num-
bers of immune cells – may be attributed in the case of
symptomatic trichomoniasis, this may not be the case
in asymptomatic infection. There is some evidence
that even in the absence of acute symptoms there may
be chronic inﬂammation of the urogenital tract [20]
and increased potential for the transmission of HIV
in men and women with trichomoniasis has been
recorded [8, 24]. However, in a cross-sectional analy-
sis such as this, it is not possible without more detailed
immunological investigations, to determine whether
such a relationship is causal or to assess a direction
of causation. Furthermore, despite the precautionary
measures that were taken to reduce misreporting,
biases in the data on sexual behaviour and/or STI-
related symptoms could mean that the full eﬀects of
the confounding factors included in the regression
models were not captured. Equally there could be
other confounding risks, common to both HIV and
T. vaginalis infection that were not measured in this
study.
Intervention studies would be needed to determine
whether there is indeed a causal association between
T. vaginalis infection and HIV. The Rakai study in
Uganda [11] failed to show that repeated mass treat-
ments for STI, including the use of metronidazole,
impacted on HIV incidence. However, there are
number of possible explanations. The occurrence of
other STIs, especially herpetic ulcers, that remained
untreated, may have masked the impact of the inter-
vention. The continued detection of trichomonal in-
fection (9–11% after intervention), of bacterial
vaginosis (46–54% after intervention) and of urethral
discharge (6–7% after intervention) suggest that the
treatment intervals may have been too long to sub-
stantially reduce these conditions, each of which may
be a risk factor for HIV infection, within the com-
munity.
In a study in Malawi, the inclusion of metro-
nidazole in syndromic management of urethritis in
men failed to reduce the prevalence of persistent
urethritis, as determined 1 week after treatment, even
though the T. vaginalis infection was eliminated [25].
Seminal HIV-1 RNA levels were, however, substan-
tially reduced in men treated for trichomoniasis, and 2
weeks after this treatment the levels in the semen of
treated men and in controls, without an STI, were
comparable [25]. Given that trichomoniasis is prob-
ably the most commonly occurring STI in Africa,
focusing treatment at this parasite may be a useful
strategy in HIV prevention programmes.
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